Delivery Order SPE2DB25D7060-SPE2DB25FXSRK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,170.56 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded a $1,052.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 18, 2025, with completion scheduled for September 19, 2025. This competitive award, which carried no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,306.32 for 100 capsules of dextroamphetamine-amphetamine 10 mg, with a completion deadline of December 8, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a discrete pharmaceutical procurement to support federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,062.60 for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.51 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 10 mg, with performance at the company's Conshohocken, Pennsylvania facility. This firm fixed-price delivery order, awarded on November 17, 2025, represents a competitive award with no set-aside designation and carries an ultimate completion date of November 18, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order valued at $1,392.76 to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) on December 10, 2025, with a completion date of December 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.34 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 10 mg on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,014.76 for Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on October 29, 2025, with completion scheduled for October 30, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order transaction under AmerisourceBergen's broader federal pharmaceutical supply agreements. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,422.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 10 mg on November 10, 2025, with completion scheduled for November 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within the company's...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSRKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,225.39 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg, with performance in Conshohocken, Pennsylvania and completion by August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts predominantly with the Defense Logistics Agency and consistently demonstrates capability to meet federal pharmaceutical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/8/25 |